LONDON (Reuters) -U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...

AS Monaco and Roche Bobois, a French brand specializing in high-end furnishings and decoration with an international ...

Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Roche committed $50 billion in U.S. manufacturing funds, with which it will construct at least four new facilities.

About a month after disclosing a $50 billion investment in its U.S. | Roche has earmarked more than $700 million to construct ...

Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...